MAYRA ZIMMERMAN: Open Payments
NPI 1629484365 · TALLAHASSEE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,339 in 78 payments from 22 companies in 2025. Trend: 2023 $2,423 · 2024 $3,352 · 2025 $3,339
Food & beverage: $1,959Consulting: $1,125Education: $255
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 9 | $1,544 |
| UCB, Inc. | 12 | $365 |
| GENZYME CORPORATION | 7 | $255 |
| ABBVIE INC. | 14 | $249 |
| Incyte Corporation | 3 | $159 |
| Novartis Pharmaceuticals Corporation | 4 | $131 |
| Regeneron Healthcare Solutions, Inc. | 5 | $112 |
| LEO Pharma Inc. | 4 | $90 |
| Journey Medical Corporation | 3 | $60 |
| SANOFI-AVENTIS U.S. LLC | 1 | $56 |
Products named: TREMFYA, DUPIXENT, Bimzelx, SKYRIZI, Opzelura, COSENTYX, ADBRY, EBGLYSS.
Industry payments across FL — which companies pay providers there.
